Danaher (NYSE:DHR) Issues FY 2025 Earnings Guidance

Key Points

• Danaher has provided FY 2025 EPS guidance of $7.700-7.800, slightly above the consensus estimate of $7.770.
• The company recently announced a quarterly dividend of $0.32 per share, representing an annualized dividend of $1.28 with a yield of 0.6%.
• Analysts generally rate Danaher as a Moderate Buy, with an average target price of $245.00, reflecting strong confidence among equity research analysts.

Danaher (NYSE:DHR - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 7.700-7.800 for the period, compared to the consensus EPS estimate of 7.770. The company issued revenue guidance of -.

Danaher Stock Down 0.5%

DHR stock opened at $208.06 on Tuesday. The company has a market cap of $148.98 billion, a price-to-earnings ratio of 44.27, a PEG ratio of 2.98 and a beta of 0.77. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher has a 12 month low of $171.00 and a 12 month high of $274.21. The firm has a 50-day moving average of $201.76 and a two-hundred day moving average of $197.42.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm's quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter last year, the company posted $1.72 EPS. As a group, analysts forecast that Danaher will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher's dividend payout ratio (DPR) is presently 27.23%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Danaher in a research report on Wednesday, October 8th. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research report on Tuesday, September 2nd. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Barclays reissued an "overweight" rating and issued a $225.00 price target (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Finally, Redburn Partners set a $220.00 price target on shares of Danaher in a research report on Wednesday, October 8th. Seventeen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $245.00.

Insider Activity

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 11.20% of the company's stock.

Institutional Investors Weigh In On Danaher

Several hedge funds and other institutional investors have recently bought and sold shares of DHR. WFA of San Diego LLC acquired a new stake in Danaher during the 2nd quarter worth $26,000. Zuckerman Investment Group LLC acquired a new position in Danaher in the second quarter valued at $222,000. Gallagher Fiduciary Advisors LLC increased its stake in Danaher by 7.5% in the second quarter. Gallagher Fiduciary Advisors LLC now owns 1,149 shares of the conglomerate's stock valued at $227,000 after purchasing an additional 80 shares during the period. 44 Wealth Management LLC increased its stake in Danaher by 7.8% in the second quarter. 44 Wealth Management LLC now owns 1,264 shares of the conglomerate's stock valued at $250,000 after purchasing an additional 92 shares during the period. Finally, HUB Investment Partners LLC increased its stake in Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock valued at $273,000 after purchasing an additional 325 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.